Effects of transforming growth factor-β and interleukin-1β on inflammatory markers of osteoarthritis in cultured canine chondrocytes

Am J Vet Res. 2017 Nov;78(11):1264-1272. doi: 10.2460/ajvr.78.11.1264.

Abstract

OBJECTIVE To determine effects of transforming growth factor (TGF)-β and interleukin (IL)-1β on inflammatory markers in cultured canine chondrocytes to clarify the role of these cytokines in osteoarthritis of dogs. SAMPLE Pooled chondrocytes isolated from the stifle joints of 4 adult dogs. PROCEDURES Chondrocytes were isolated, cultured, and frozen at -80°C. Pooled cells were incubated in medium with or without TGF-β (1 or 10 ng/mL) and subsequently stimulated with IL-1β (10 ng/mL). Concentrations of nitric oxide (NO) and prostaglandin (PG) E were measured in culture supernatants. Gene expression of matrix metalloproteinase (MMP)-3, tissue inhibitor of metalloproteinase (TIMP)-2, inducible NO synthase (iNOS), and cyclooxygenase (COX)-2 was quantified by use of real-time quantitative PCR assays. RESULTS Stimulation with IL-1β increased gene expression of all inflammatory markers, except for TIMP-2. Incubation with TGF-β resulted in a significant decrease in MMP-3 and TIMP-2 mRNA concentrations but had no effect on PGE and NO concentrations. For cells treated with TGF-β followed by IL-1β, concentrations of PGE and NO were lower, compared with concentrations for IL-1β control cells. Furthermore, IL-1β-induced gene expression of iNOS, MMP-3, and COX-2 was downregulated. However, the IL-1β-induced downregulation of TIMP-2 gene expression was partially restored by pretreatment with TGF-β. CONCLUSIONS AND CLINICAL RELEVANCE Results indicated that IL-1β increased the expression of inflammatory genes and mediators, and TGF-β largely attenuated the IL-1β-mediated inflammatory response. Therefore, TGF-β might be a novel target for use in the prevention and treatment of cartilage breakdown in dogs with osteoarthritis.

MeSH terms

  • Animals
  • Cartilage / metabolism
  • Cells, Cultured
  • Chondrocytes / drug effects*
  • Chondrocytes / metabolism
  • Cyclooxygenase 2 / metabolism
  • Dog Diseases / drug therapy*
  • Dog Diseases / genetics
  • Dogs
  • Gene Expression
  • Inflammation Mediators / metabolism
  • Interleukin-1beta / genetics
  • Interleukin-1beta / pharmacology*
  • Matrix Metalloproteinase 3 / genetics
  • Nitric Oxide / metabolism
  • Nitric Oxide Synthase Type II / genetics
  • Osteoarthritis / drug therapy
  • Osteoarthritis / metabolism
  • Osteoarthritis / veterinary*
  • Tissue Inhibitor of Metalloproteinase-2 / genetics
  • Transforming Growth Factor beta / genetics
  • Transforming Growth Factor beta / pharmacology*

Substances

  • Inflammation Mediators
  • Interleukin-1beta
  • Transforming Growth Factor beta
  • Tissue Inhibitor of Metalloproteinase-2
  • Nitric Oxide
  • Nitric Oxide Synthase Type II
  • Cyclooxygenase 2
  • Matrix Metalloproteinase 3